Commission of the European Communities v Les Laboratoires Servier SA.

Afectaciones

WORK EXPRESSION OF por

• Commission of the European Communities v Les Laboratoires Servier SA.

Documentos citados

• Claude Willeme v Commission of the European Communities.
• J. Antonissen contra Comisión de las Comunidades Europeas y Consejo de la Unión Europea.
• Commission of the European Communities v National Association of Licensed Opencast Operators (NALOO).
• Commission of the European Communities v Artegodan GmbH and Others.
• Les Laboratoires Servier v Commission of the European Communities.



Ver todas las citas

• European Parliament v Jack Hanning.
• Reinaldus Renckens v Commission of the European Communities.
• Artegodan GmbH and Others v Commission of the European Communities.
• DSR-Senator Lines GmbH v Commission of the European Communities.
• Pfizer Animal Health SA and Others v Commission of the European Communities and Others.
• Federal Republic of Germany v Commission of the European Communities.
• Luigi Marcuccio v Commission of the European Communities.
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Council Directive 93/39/EEC of 14 June 1993 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC in respect of medicinal products
• Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products
• Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
• Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products
• Council Directive 89/341/EEC of 3 May 1989 amending Directives 65/65/EEC, 75/318/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products
• Council Directive 87/22/EEC of 22 December 1986 on the approximation of national measures relating to the placing on the market of high-technology medicinal products, particularly those derived from biotechnology
• Treaty establishing the European Community